Jin-Feng Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jin-Feng Xu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Peng
State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
3 shared publications - Fei Tang
State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
3 shared publications - Hui Ao
State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
3 shared publications - Lu Chen
State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
3 shared publications - Yan Wan
Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
3 shared publications - Jia Xia
Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
2 shared publications
Latest Publications
- Open Access
- 6 August 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 153, 113421
Can aloin develop to medicines or healthcare products?
- 6 August 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 153, 113421
Open AccessCan aloin develop to medicines or healthcare products?
- Open Access
- 3 June 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 152, 113207
New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease
- 3 June 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 152, 113207
Open AccessNew insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease
- 1 January 2022
- Published by Elsevier in Pharmacological Research
- Vol. 175, 106002
Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases
- 1 January 2022
- Published by Elsevier in Pharmacological Research
- Vol. 175, 106002
Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases